相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabolism in Huntington's disease: a major contributor to pathology
Akanksha Singh et al.
METABOLIC BRAIN DISEASE (2022)
Compartmentalization of Sphingolipid metabolism: Implications for signaling and therapy
Daniel Canals et al.
PHARMACOLOGY & THERAPEUTICS (2022)
Diffusion imaging in Huntington's disease: comprehensive review
Carlos Estevez-Fraga et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)
The rapidly evolving view of lysosomal storage diseases
Giancarlo Parenti et al.
EMBO MOLECULAR MEDICINE (2021)
An imaging mass spectrometry atlas of lipids in the human neurologically normal and Huntington's disease caudate nucleus
Mandana Hunter et al.
JOURNAL OF NEUROCHEMISTRY (2021)
Evaluation of early microstructural changes in the R6/1 mouse model of Huntington's disease by ultra-high field diffusion MR imaging
Rodolfo G. Gatto et al.
NEUROBIOLOGY OF AGING (2021)
Nuclear and cytoplasmic huntingtin inclusions exhibit distinct biochemical composition, interactome and ultrastructural properties
Nathan Riguet et al.
NATURE COMMUNICATIONS (2021)
Programming to S1PR1+ Endothelial Cells Promotes Restoration of Vascular Integrity
Md Zahid Akhter et al.
CIRCULATION RESEARCH (2021)
Molecular Strategies to Target Protein Aggregation in Huntington's Disease
Olga D. Jarosinska et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Sphingolipids metabolism alteration in the central nervous system: Amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases
Alexandra Bouscary et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2021)
Systemic manifestation and contribution of peripheral tissues to Huntington's disease pathogenesis
Chia-Lung Chuang et al.
AGEING RESEARCH REVIEWS (2021)
Novelty of Sphingolipids in the Central Nervous System Physiology and Disease: Focusing on the Sphingolipid Hypothesis of Neuroinflammation and Neurodegeneration
Maria Ayub et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Spns2 Transporter Contributes to the Accumulation of S1P in Cystic Fibrosis Human Bronchial Epithelial Cells
Aida Zulueta et al.
BIOMEDICINES (2021)
The Discovery of Highly Potent THP Derivatives as OCTN2 Inhibitors: From Structure-Based Virtual Screening to In Vivo Biological Activity
Francesca Di Cristo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Pharmacological inhibition of sphingosine-1-phosphate lyase partially reverses spatial memory impairment in streptozotocin-diabetic rats
Urszula Baranowska et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2020)
Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities
Sarah J. Tabrizi et al.
NATURE REVIEWS NEUROLOGY (2020)
Treatment with K6PC-5, a selective stimulator of SPHK1, ameliorates intestinal homeostasis in an animal model of Huntington's disease
A. Di Pardo et al.
NEUROBIOLOGY OF DISEASE (2020)
The contribution of glial cells to Huntington's disease pathogenesis
Daniel K. Wilton et al.
NEUROBIOLOGY OF DISEASE (2020)
Neurodegeneration Caused by S1P-Lyase Deficiency Involves Calcium-Dependent Tau Pathology and Abnormal Histone Acetylation
Shah Alam et al.
CELLS (2020)
Analysis of mutant and total huntingtin expression in Huntington's disease murine models
Valentina Fodale et al.
SCIENTIFIC REPORTS (2020)
Influence of Normal Aging on Brain Autophagy: A Complex Scenario
David A. Loeffler
FRONTIERS IN AGING NEUROSCIENCE (2019)
Stimulation of Sphingosine Kinase 1 (SPHK1) Is Beneficial in a Huntington's Disease Pre-clinical Model
Alba Di Pardo et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
SPNS2 promotes the malignancy of colorectal cancer cells via regulating Akt and ERK pathway
Xinyue Gu et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2019)
The Link between Gaucher Disease and Parkinson's Disease Sheds Light on Old and Novel Disorders of Sphingolipid Metabolism
Rossella Indellicato et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases
Sara Grassi et al.
FRONTIERS IN PHARMACOLOGY (2019)
The pathobiology of perturbed mutant huntingtin protein-protein interactions in Huntington's disease
Erich E. Wanker et al.
JOURNAL OF NEUROCHEMISTRY (2019)
Glucocerebrosidase and its relevance to Parkinson disease
Jenny Do et al.
MOLECULAR NEURODEGENERATION (2019)
Effects of the synthetic estrogen 17-α-ethinylestradiol on Drosophila melanogaster: Dose and gender dependence
Tiziana Francesca Bovier et al.
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY (2018)
Caramel color safety - An update
Thomas A. Vollmuth
FOOD AND CHEMICAL TOXICOLOGY (2018)
Stimulation of S1PR(5) with A-971432, a selective agonist, preserves blood-brain barrier integrity and exerts therapeutic effect in an animal model of Huntington's disease
Alba Di Pardo et al.
HUMAN MOLECULAR GENETICS (2018)
Golgi stress response reprograms cysteine metabolism to confer cytoprotection in Huntington's disease
Juan I. Sbodio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
The S1P Axis: New Exciting Route for Treating Huntington's Disease
Alba Di Pardo et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
The clinical efficacy of imiglucerase versus eliglustat in patients with Gaucher's disease Type 1: A systematic review
Azita Nabizadeh et al.
JOURNAL OF RESEARCH IN PHARMACY PRACTICE (2018)
Inhibiting sphingosine kinase 2 mitigates mutant Huntingtin-induced neurodegeneration in neuron models of Huntington disease
Jose F. Moruno-Manchon et al.
HUMAN MOLECULAR GENETICS (2017)
Lipids regulate the hydrolysis of membrane bound glucosylceramide by lysosomal β-glucocerebrosidase
Misbaudeen Abdul-Hammed et al.
JOURNAL OF LIPID RESEARCH (2017)
The metabolism of glucocerebrosides - From 1965 to the present
Anthony H. Futerman et al.
MOLECULAR GENETICS AND METABOLISM (2017)
Sphingosine-1-phosphate receptor therapies: Advances in clinical trials for CNS-related diseases
Sinead O'Sullivan et al.
NEUROPHARMACOLOGY (2017)
Identifying therapeutic targets by combining transcriptional data with ordinal clinical measurements
Leila Pirhaji et al.
NATURE COMMUNICATIONS (2017)
De novo Synthesis of Sphingolipids Is Defective in Experimental Models of Huntington's Disease
Alba Di Pardo et al.
FRONTIERS IN NEUROSCIENCE (2017)
Quantification of huntingtin protein species in Huntington's disease patient leukocytes using optimised electrochemiluminescence immunoassays
Davina J. Hensman Moss et al.
PLOS ONE (2017)
Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease
Alba Di Pardo et al.
SCIENTIFIC REPORTS (2017)
SGPL1 (sphingosine phosphate lyase 1) modulates neuronal autophagy via phosphatidylethanolamine production
Daniel N. Mitroi et al.
AUTOPHAGY (2017)
Reduced bioavailable manganese causes striatal urea cycle pathology in Huntington's disease mouse model
Terry Jo V. Bichell et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Revealing disease-associated pathways by network integration of untargeted metabolomics
Leila Pirhaji et al.
NATURE METHODS (2016)
To fingolimod and beyond: The rich pipeline of drug candidates that target S1P signaling
Wee Siong Chew et al.
PHARMACOLOGICAL RESEARCH (2016)
PSD-95 stabilizes NMDA receptors by inducing the degradation of STEP61
Sehoon Won et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Sphingosine 1-phosphate lyase ablation disrupts presynaptic architecture and function via an ubiquitin-proteasome mediated mechanism
Daniel N. Mitroi et al.
SCIENTIFIC REPORTS (2016)
Real-time imaging of Huntingtin aggregates diverting target search and gene transcription
Li Li et al.
ELIFE (2016)
Impaired Levels of Gangliosides in the Corpus Callosum of Huntington Disease Animal Models
Alba Di Pardo et al.
FRONTIERS IN NEUROSCIENCE (2016)
Up-Regulated Expression of LAMP2 and Autophagy Activity during Neuroendocrine Differentiation of Prostate Cancer LNCaP Cells
Cecilia Morell et al.
PLOS ONE (2016)
Rapid evaluation of 25 key sphingolipids and phosphosphingolipids in human plasma by LC-MS/MS
Abdul Basit et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2015)
Amyotrophic lateral sclerosis and denervation alter sphingolipids and up-regulate glucosylceramide synthase
Alexandre Henriques et al.
HUMAN MOLECULAR GENETICS (2015)
Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis
James C. Dodge et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Cytoplasmic sphingosine-1-phosphate pathway modulates neuronal autophagy
Jose Felix Moruno Manchon et al.
SCIENTIFIC REPORTS (2015)
Higher level of plasma bioactive molecule sphingosine 1-phosphate in women is associated with estrogen
Shoudong Guo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2014)
Sphingosine-l-Phosphate: Boon and Bane for the Brain
Gerhild van Echten-Deckert et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
MRI measures of corpus callosum iron and myelin in early Huntington's disease
M. Di Paola et al.
HUMAN BRAIN MAPPING (2014)
FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease
Alba Di Pardo et al.
HUMAN MOLECULAR GENETICS (2014)
Therapeutic Approaches for Inhibition of Protein Aggregation in Huntington's Disease
Sangjune Kim et al.
Experimental Neurobiology (2014)
Inhibition of sphingosine-1-phosphate lyase rescues sphingosine kinase-1-knockout phenotype following murine cardiac arrest
Irina A. Gorshkova et al.
LIFE SCIENCES (2013)
Partial Deficiency of Sphingosine-1-Phosphate Lyase Confers Protection in Experimental Autoimmune Encephalomyelitis
Andreas Billich et al.
PLOS ONE (2013)
Changes of peripheral TGF-β1 depend on monocytes-derived macrophages in Huntington disease
Alba Di Pardo et al.
MOLECULAR BRAIN (2013)
Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease
Eve M. Dumas et al.
HUMAN BRAIN MAPPING (2012)
Huntington's Disease and the Striatal Medium Spiny Neuron: Cell-Autonomous and Non-Cell-Autonomous Mechanisms of Disease
Michelle E. Ehrlich
NEUROTHERAPEUTICS (2012)
Comprehensive Behavioral and Molecular Characterization of a New Knock-In Mouse Model of Huntington's Disease: zQ175
Liliana B. Menalled et al.
PLOS ONE (2012)
Sphingosine-1-phosphate signaling and its role in disease
Michael Maceyka et al.
TRENDS IN CELL BIOLOGY (2012)
Sphingosine-1-phosphate links glycosphingolipid metabolism to neurodegeneration via a calpain-mediated mechanism
N. Hagen et al.
CELL DEATH AND DIFFERENTIATION (2011)
Lipids and Cholesterol as Regulators of Traffic in the Endomembrane System
Jennifer Lippincott-Schwartz et al.
ANNUAL REVIEW OF BIOPHYSICS, VOL 39 (2010)
Immunosuppressive effects of 2-acetyl-4-tetrahydroxybutyl imidazole (THI) in the rat
S. J. P. GOBIN et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Cerebellar lipid differences between R6/1 transgenic mice and humans with Huntington's disease
Christine A. Denny et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Impaired Ganglioside Metabolism in Huntington's Disease and Neuroprotective Role of GM1
Vittorio Maglione et al.
JOURNAL OF NEUROSCIENCE (2010)
Pharmacokinetic/pharmacodynamic modelling of 2-acetyl-4(5)-tetrahydroxybutyl imidazole-induced peripheral lymphocyte sequestration through increasing lymphoid sphingosine 1-phosphate
X. Q. Yu et al.
XENOBIOTICA (2010)
Subcellular Origin of Sphingosine 1-Phosphate Is Essential for Its Toxic Effect in Lyase-deficient Neurons
Nadine Hagen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function
Paul Saftig et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Striatal Medium-Sized Spiny Neurons: Identification by Nuclear Staining and Study of Neuronal Subpopulations in BAC Transgenic Mice
Miriam Matamales et al.
PLOS ONE (2009)
Huntingtin as an essential integrator of intracellular vesicular trafficking
Juliane P. Caviston et al.
TRENDS IN CELL BIOLOGY (2009)
Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide
Giovanni D'Angelo et al.
NATURE (2007)
Glycolipid and ganglioside metabolism imbalances in Huntington's disease
Paula A. Desplats et al.
NEUROBIOLOGY OF DISEASE (2007)
Intracellular trafficking of sphingolipids: Relationship to biosynthesis
Anthony H. Futerman
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2006)
Epitope mapping of monoclonal antibody 4C8 recognizing the protein Huntingtin
SY Cong et al.
HYBRIDOMA (2005)
PDZ domain proteins of synapses
EJ Kim et al.
NATURE REVIEWS NEUROSCIENCE (2004)
Fly models of Huntington's disease
JL Marsh et al.
HUMAN MOLECULAR GENETICS (2003)
The organizing potential of sphingolipids in intracellular membrane transport
JCM Holthuis et al.
PHYSIOLOGICAL REVIEWS (2001)
Interference by Huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity
FC Nucifora et al.
SCIENCE (2001)
Loss of normal huntingtin function: new developments in Huntington's disease research
E Cattaneo et al.
TRENDS IN NEUROSCIENCES (2001)
Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in Hdh(Q92) and Hdh(Q111) knock-in mice
VC Wheeler et al.
HUMAN MOLECULAR GENETICS (2000)
分享论文
